• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Age modifies both the maximal temperature and inflammatory response in patients with SARS-CoV-2 infection.年龄会影响 SARS-CoV-2 感染患者的最高体温和炎症反应。
Clin Med (Lond). 2022 May;22(3):192-196. doi: 10.7861/clinmed.2021-0603.
2
Comparative analysis of C-Reactive protein levels among Non-comorbid, Comorbid, and Multimorbid Hospitalized COVID-19 patients.非合并症、合并症和多重合并症住院COVID-19患者C反应蛋白水平的比较分析。
BMC Infect Dis. 2025 Jan 14;25(1):59. doi: 10.1186/s12879-024-10314-2.
3
C-reactive protein cut-off for early tocilizumab and dexamethasone prescription in hospitalized patients with COVID-19.新冠住院患者早期使用托珠单抗和地塞米松处方的C反应蛋白临界值
Sci Rep. 2022 Mar 28;12(1):5250. doi: 10.1038/s41598-022-08882-x.
4
Short-Term Dexamethasone in Sars-CoV-2 Patients.新冠病毒患者的短期地塞米松治疗
R I Med J (2013). 2020 Jun 19;103(6):39-43.
5
Interplay of inflammatory markers and anti-SARS-CoV-2 antibodies in COVID-19 mortality: A prospective cohort study.COVID-19 死亡率中炎症标志物与抗 SARS-CoV-2 抗体的相互作用:一项前瞻性队列研究。
Int J Infect Dis. 2024 Jun;143:107016. doi: 10.1016/j.ijid.2024.107016. Epub 2024 Mar 22.
6
Treatment of COVID-19 pneumonia with glucocorticoids (CORTIVID): a structured summary of a study protocol for a randomised controlled trial.COVID-19 肺炎的糖皮质激素(CORTIVID)治疗:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):43. doi: 10.1186/s13063-020-04999-4.
7
New York Inner City Hospital COVID-19 Experience and Current Data: Retrospective Analysis at the Epicenter of the American Coronavirus Outbreak.纽约市中心医院新冠肺炎的经历与当前数据:美国新冠疫情中心的回顾性分析
J Med Internet Res. 2020 Sep 18;22(9):e20548. doi: 10.2196/20548.
8
The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy-A Prospective Longitudinal Study.免疫和临床生物标志物在预测 COVID-19 临床严重程度和治疗反应中的作用:一项前瞻性纵向研究。
Front Immunol. 2021 Mar 17;12:646095. doi: 10.3389/fimmu.2021.646095. eCollection 2021.
9
Prognostic factors in patients admitted to an urban teaching hospital with COVID-19 infection.城市教学医院 COVID-19 感染住院患者的预后因素。
J Transl Med. 2020 Sep 15;18(1):354. doi: 10.1186/s12967-020-02524-4.
10
Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia.地塞米松与甲泼尼龙大剂量治疗新冠肺炎肺炎。
PLoS One. 2021 May 25;16(5):e0252057. doi: 10.1371/journal.pone.0252057. eCollection 2021.

引用本文的文献

1
C-reactive protein in the first 30 postoperative days and its discriminative value as a marker for postoperative infections, a multicentre cohort study.术后30天内的C反应蛋白及其作为术后感染标志物的鉴别价值:一项多中心队列研究
BMJ Open. 2025 Apr 22;15(4):e093615. doi: 10.1136/bmjopen-2024-093615.
2
Anaemia of acute inflammation: a higher acute systemic inflammatory response is associated with a larger decrease in blood haemoglobin levels in patients with COVID-19 infection.急性炎症性贫血:急性全身性炎症反应较高的 COVID-19 感染患者的血液血红蛋白水平下降幅度更大。
Clin Med (Lond). 2023 May;23(3):201-205. doi: 10.7861/clinmed.2022-0436. Epub 2023 May 17.
3
Doing what's necessary becomes doing what is possible.做必要之事,就会成为做可能之事。
Clin Med (Lond). 2022 May;22(3):191. doi: 10.7861/clinmed.ed.22.3.1.

本文引用的文献

1
The role of C-reactive protein as a prognostic marker in COVID-19.C反应蛋白在2019冠状病毒病中作为预后标志物的作用。
Int J Epidemiol. 2021 May 17;50(2):420-429. doi: 10.1093/ije/dyab012.
2
Immunosenescence: a key player in cancer development.免疫衰老:癌症发展中的关键因素。
J Hematol Oncol. 2020 Nov 10;13(1):151. doi: 10.1186/s13045-020-00986-z.
3
Demographic perspectives on the mortality of COVID-19 and other epidemics.人口统计学视角下的 COVID-19 和其他传染病的死亡率。
Proc Natl Acad Sci U S A. 2020 Sep 8;117(36):22035-22041. doi: 10.1073/pnas.2006392117. Epub 2020 Aug 20.
4
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
5
Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention.免疫衰老及其特征:如何战略性地对抗衰老?治疗干预潜在选择的综述。
Front Immunol. 2019 Sep 25;10:2247. doi: 10.3389/fimmu.2019.02247. eCollection 2019.
6
Understanding immunosenescence to improve responses to vaccines.了解免疫衰老以提高疫苗反应。
Nat Immunol. 2013 May;14(5):428-36. doi: 10.1038/ni.2588. Epub 2013 Apr 18.
7
1918 Influenza: the mother of all pandemics.1918年流感:所有大流行之母。
Emerg Infect Dis. 2006 Jan;12(1):15-22. doi: 10.3201/eid1201.050979.
8
Fever in the elderly.老年人发热
Clin Infect Dis. 2000 Jul;31(1):148-51. doi: 10.1086/313896. Epub 2000 Jul 25.
9
Inflation in epidemiology: "the proof and measurement of association between two things" revisited.流行病学中的Inflation:重温“两件事之间关联的证明与测量”
BMJ. 1996 Jun 29;312(7047):1659-61. doi: 10.1136/bmj.312.7047.1659.

年龄会影响 SARS-CoV-2 感染患者的最高体温和炎症反应。

Age modifies both the maximal temperature and inflammatory response in patients with SARS-CoV-2 infection.

机构信息

Nottingham Digestive Diseases Centre, Nottingham, UK, NIHR Nottingham Biomedical Research Centre, Nottingham, UK and Nottingham University Hospitals NHS Trust, Nottingham, UK.

University of Nottingham, Nottingham, UK, NIHR Nottingham Biomedical Research Centre, Nottingham, UK, Nottingham University Hospitals NHS Trust, Nottingham, UK and East Midlands Academic Health Science Network, Nottingham, UK.

出版信息

Clin Med (Lond). 2022 May;22(3):192-196. doi: 10.7861/clinmed.2021-0603.

DOI:10.7861/clinmed.2021-0603
PMID:35584822
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9135072/
Abstract

OBJECTIVE

To determine the maximal response of the temperature and inflammatory response to SARS-CoV-2 infection and how these are modified by age.

METHODS

Participants were patients admitted to hospital with SARS-CoV-2 infection. For each participant, the maximal temperature and serum C-reactive protein (CRP) were identified and stratified by age. In a secondary analysis, these were compared in patients treated before and after dexamethasone.

RESULTS

Mean maximal temperature varied by age (p<0.001; ANOVA) with the highest mean maximal temperature of 37.3°C observed in patients aged 30-49 years and decreasing maximal mean temperatures in the older age groups, with the lowest measure of 36.8°C observed in individuals aged 90-99 years. The mean maximal serum CRP also varied across age groups (p<0.001; ANOVA) and increased with age across all age categories from 34.5 mg/dL (95% confidence interval (CI) 22.0-47.0) for individuals aged 20-29 years to 77.6 mg/dL (95% CI 72.0-83.2) in those aged 80-89 years. After dexamethasone became standard treatment for COVID-19 pneumonia, mean maximal CRP decreased by 17 mg/dL (95% CI -22 to -11).

CONCLUSION

Age modifies both maximal temperature and systemic inflammatory response in patients with SARS-CoV-2 infection.

摘要

目的

确定体温和炎症反应对 SARS-CoV-2 感染的最大反应以及年龄如何对此产生影响。

方法

研究对象为因 SARS-CoV-2 感染而住院的患者。对每位患者的最高体温和血清 C 反应蛋白(CRP)进行了确定,并按年龄进行了分层。在二次分析中,比较了地塞米松治疗前后患者的这些指标。

结果

平均最高体温因年龄而异(p<0.001;方差分析),30-49 岁患者的平均最高体温最高,为 37.3°C,年龄较大的患者体温逐渐降低,90-99 岁患者的平均最高体温最低,为 36.8°C。平均最高血清 CRP 也随年龄组而变化(p<0.001;方差分析),所有年龄组的 CRP 均随年龄的增加而增加,从 20-29 岁患者的 34.5mg/dL(95%置信区间[CI] 22.0-47.0)到 80-89 岁患者的 77.6mg/dL(95% CI 72.0-83.2)。地塞米松成为 COVID-19 肺炎的标准治疗方法后,平均最高 CRP 下降了 17mg/dL(95% CI -22 至-11)。

结论

年龄会改变 SARS-CoV-2 感染患者的最高体温和全身炎症反应。